Application
Western blot analysis of RAT STX3 Antibody (Center) in rat cerebellum, liver tissue lysates (35ug/lane). STX3 (arrow) was detected using the purified Pab.Application
Formalin-fixed and paraffin-embedded human hepatocarcinoma with RAT STX3 Antibody (Center), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Product Name | RAT STX3 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | Stx3; Stx3a; Syntaxin-3 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | Stx3a |
|---|---|
| Alternative Names | Stx3 Stx3a Syntaxin-3 |
| Molecular Weight(MW) | 33257 Da |
| Function | Potentially involved in docking of synaptic vesicles at presynaptic active zones |
| Tissue Specificity | Heart, spleen, lung and kidney. |
| Cellular Localization | Membrane; Single-pass type IV membrane protein (Potential) |
| Entrez Gene | 81802 |
|---|
Application
Western blot analysis of RAT STX3 Antibody (Center) in rat cerebellum, liver tissue lysates (35ug/lane). STX3 (arrow) was detected using the purified Pab.
Application
Formalin-fixed and paraffin-embedded human hepatocarcinoma with RAT STX3 Antibody (Center), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
